PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 256 filers reported holding PACIRA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 2.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $229,000 | -61.1% | 4,304 | -57.4% | 0.08% | -60.5% |
| Q2 2022 | $589,000 | -24.6% | 10,100 | -1.3% | 0.22% | -12.6% |
| Q1 2022 | $781,000 | +32.8% | 10,232 | +4.8% | 0.25% | +35.2% |
| Q4 2021 | $588,000 | -33.9% | 9,768 | -38.6% | 0.18% | -37.7% |
| Q3 2021 | $890,000 | -7.8% | 15,897 | 0.0% | 0.29% | -4.9% |
| Q2 2021 | $965,000 | +11.2% | 15,897 | +28.4% | 0.31% | +7.0% |
| Q1 2021 | $868,000 | +21.6% | 12,379 | +3.8% | 0.29% | +13.0% |
| Q4 2020 | $714,000 | +88.9% | 11,927 | +89.6% | 0.25% | +67.1% |
| Q3 2020 | $378,000 | – | 6,290 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Key Colony Management, LLC | 134,600 | $13,045,000 | 11.31% |
| Biondo Investment Advisors, LLC | 279,717 | $27,110,000 | 8.33% |
| GILDER GAGNON HOWE & CO LLC | 3,177,130 | $307,927,000 | 4.48% |
| DARUMA CAPITAL MANAGEMENT LLC | 814,470 | $78,938,000 | 3.47% |
| MAGEE THOMSON INVESTMENT PARTNERS LLC | 126,022 | $12,214,000 | 3.01% |
| NEXT CENTURY GROWTH INVESTORS LLC | 768,396 | $74,472,000 | 2.63% |
| MARXE AUSTIN W & GREENHOUSE DAVID M | 180,000 | $17,446,000 | 2.38% |
| Lisanti Capital Growth, LLC | 48,280 | $4,679,000 | 2.35% |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC | 79,017 | $7,658,000 | 2.00% |
| Atika Capital Management LLC | 21,500 | $2,084,000 | 1.60% |